SCYNEXIS, Inc. - 11 Year Stock Price History | SCYX

Historical daily share price chart and data for SCYNEXIS, Inc. since 2014 adjusted for splits and dividends. The latest closing stock price for SCYNEXIS, Inc. as of February 21, 2025 is 1.07.
  • The all-time high SCYNEXIS, Inc. stock closing price was 145.00 on January 12, 2015.
  • The SCYNEXIS, Inc. 52-week high stock price is 3.07, which is 186.9% above the current share price.
  • The SCYNEXIS, Inc. 52-week low stock price is 0.90, which is 15.9% below the current share price.
  • The average SCYNEXIS, Inc. stock price for the last 52 weeks is 1.58.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
SCYNEXIS, Inc. Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 1.1521 1.4500 1.4500 1.0200 1.0700 -11.57%
2024 1.6885 2.2100 2.7700 0.9902 1.2100 -45.74%
2023 2.3503 1.4400 3.6700 1.1500 2.2300 42.95%
2022 2.9533 6.6600 6.6600 1.4600 1.5600 -74.43%
2021 7.1807 7.1700 9.9700 4.9400 6.1000 -20.26%
2020 7.3415 8.9700 11.5000 4.2800 7.6500 -15.93%
2019 11.8793 5.4410 18.5000 5.4410 9.1000 88.91%
2018 13.8169 22.8000 24.2000 3.8330 4.8170 -79.24%
2017 22.9631 34.0000 37.2000 15.6000 23.2000 -27.27%
2016 36.2430 61.0000 61.0000 18.7000 31.9000 -48.63%
2015 83.4816 99.6000 145.0000 57.7000 62.1000 -37.78%
Sector Industry Market Cap Revenue
Medical MED-DRUGS $0.041B $0.140B
SCYNEXIS, Inc. is a pharmaceutical company. It is engaged in the discovery, development, and commercialization of anti-infectives to address unmet therapeutic needs. The Company is developing its lead product candidate, SCY-078, as an oral and intravenous (IV) drug for the treatment of serious and life-threatening invasive fungal infections in humans. It also provides contract research and development services. SCYNEXIS, Inc. is headquartered in Durham, North Carolina.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) JP $83.888B 33.10
Zoetis Inc. (ZTS) US $71.853B 27.10
Takeda Pharmaceutical Co. (TAK) JP $44.737B 9.90
Daiichi Sankyo Co., Ltd. - Sponsored ADR (DSNKY) JP $43.224B 26.34
Sandoz Group AG Sponsored ADR (SDZNY) CH $20.442B 0.00
Merck KGaA (MKKGY) DE $18.230B 16.33
Astellas Pharma Inc. (ALPMY) JP $17.608B 12.47
Summit Therapeutics PLC (SMMT) US $16.312B 0.00
United Therapeutics Corporation (UTHR) US $16.121B 15.86
Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) JP $12.709B 0.00
Neurocrine Biosciences, Inc. (NBIX) US $12.033B 36.68
Orion OYJ Unsponsored ADR (ORINY) FI $7.681B 21.59
Madrigal Pharmaceuticals, Inc. (MDGL) US $7.333B 0.00
Corcept Therapeutics Incorporated (CORT) US $6.657B 50.43
Stevanato Group S.p.A. (STVN) IT $6.329B 40.98
Hikma Pharmaceuticals Plc (HKMPF) GB $6.245B 0.00
Ionis Pharmaceuticals, Inc. (IONS) US $5.138B 0.00
Grifols, S.A. (GRFS) ES $5.122B 0.00
Ono Pharmaceutical Co. (OPHLF) JP $4.650B 9.52
Recursion Pharmaceuticals, Inc. (RXRX) US $3.626B 0.00
Crinetics Pharmaceuticals, Inc. (CRNX) US $3.474B 0.00
Catalyst Pharmaceuticals, Inc. (CPRX) US $2.579B 11.69
AMNEAL PHARMACEUTICALS, INC. (AMRX) US $2.426B 14.50
Centessa Pharmaceuticals PLC Sponsored ADR (CNTA) GB $2.193B 0.00
Hypermarcas (HYPMY) BR $2.154B 0.00
Soleno Therapeutics, Inc. (SLNO) US $1.989B 0.00
BioCryst Pharmaceuticals, Inc. (BCRX) US $1.908B 0.00
NewAmsterdam Pharma Company N.V. (NAMS) NL $1.716B 0.00
Evotec AG (EVO) DE $1.573B 0.00
Dyne Therapeutics, Inc. (DYN) US $1.426B 0.00
Guardian Pharmacy Services, Inc. (GRDN) US $1.239B 0.00
Ardelyx, Inc. (ARDX) US $1.198B 0.00
Indivior PLC (INDV) US $1.165B 5.06
Aurinia Pharmaceuticals Inc (AUPH) CA $1.135B 0.00
Xencor, Inc. (XNCR) US $1.102B 0.00
Ocular Therapeutix, Inc. (OCUL) US $1.101B 0.00
ARS Pharmaceuticals, Inc. (SPRY) US $1.092B 0.00
Enliven Therapeutics, Inc. (ELVN) US $1.065B 0.00
Harrow, Inc. (HROW) US $1.031B 0.00
Collegium Pharmaceutical, Inc. (COLL) US $0.939B 5.13
Bioventus Inc. (BVS) US $0.812B 25.67
Avadel Pharmaceuticals PLC. (AVDL) IE $0.810B 0.00
Cronos Group Inc. (CRON) CA $0.754B 0.00
Relay Therapeutics, Inc. (RLAY) US $0.656B 0.00
Verve Therapeutics, Inc. (VERV) US $0.616B 0.00
USANA Health Sciences, Inc. (USNA) US $0.606B 11.23
Xeris Biopharma Holdings, Inc. (XERS) US $0.559B 0.00
Elite Pharmaceuticals Inc. (ELTP) US $0.521B 0.00
OmniAb, Inc. (OABI) US $0.515B 0.00
KalVista Pharmaceuticals, Inc. (KALV) US $0.496B 0.00
Savara Inc. (SVRA) US $0.462B 0.00
Theravance Biopharma, Inc. (TBPH) KY $0.458B 0.00
Altimmune, Inc. (ALT) US $0.457B 0.00
ProKidney Corp. (PROK) US $0.437B 0.00
Siga Technologies Inc. (SIGA) US $0.422B 4.92
Zevra Therapeutics, Inc. (ZVRA) US $0.410B 0.00
Organogenesis (ORGO) US $0.404B 0.00
Aldeyra Therapeutics, Inc. (ALDX) US $0.398B 0.00
Akebia Therapeutics, Inc. (AKBA) US $0.393B 0.00
Oruka Therapeutics, Inc. (ORKA) US $0.386B 0.00
CytoDyn Inc. (CYDY) US $0.368B 0.00
Esperion Therapeutics, Inc. (ESPR) US $0.359B 0.00
Rigel Pharmaceuticals, Inc. (RIGL) US $0.354B 143.50
Tourmaline Bio, Inc. (TRML) US $0.313B 0.00
Ironwood Pharmaceuticals, Inc. (IRWD) US $0.290B 0.00
Aquestive Therapeutics, Inc. (AQST) US $0.274B 0.00
Heron Therapeutics, Inc. (HRTX) US $0.263B 0.00
Avita Medical Inc. (RCEL) US $0.256B 0.00
Nature's Sunshine Products, Inc. (NATR) US $0.252B 14.98
Korro Bio, Inc. (KRRO) US $0.246B 0.00
Innate Pharma SA (IPHYF) FR $0.243B 0.00
Amylyx Pharmaceuticals, Inc. (AMLX) US $0.226B 0.00
Profound Medical (PROF) CA $0.225B 0.00
4D Molecular Therapeutics, Inc. (FDMT) US $0.215B 0.00
Inhibikase Therapeutics, Inc. (IKT) US $0.206B 0.00
Lyell Immunopharma, Inc. (LYEL) US $0.205B 0.00
Larimar Therapeutics, Inc. (LRMR) US $0.204B 0.00
MediWound Ltd. (MDWD) IL $0.191B 0.00
Nanobiotix S.A. Sponsored ADR (NBTX) FR $0.177B 0.00
Acrivon Therapeutics, Inc. (ACRV) US $0.172B 0.00
Nektar Therapeutics (NKTR) US $0.172B 0.00
Enanta Pharmaceuticals, Inc. (ENTA) US $0.171B 0.00
VAXART, INC. (VXRT) US $0.162B 0.00
Aclaris Therapeutics, Inc. (ACRS) US $0.160B 0.00
Silence Therapeutics PLC Sponsored ADR (SLN) GB $0.143B 0.00
Champions Oncology, Inc. (CSBR) US $0.141B 0.00
Inotiv, Inc. (NOTV) US $0.137B 0.00
Lexeo Therapeutics, Inc. (LXEO) US $0.129B 0.00
Procaps Group, S.A. (PROCF) LU $0.126B 0.00
Cassava Sciences, Inc. (SAVA) US $0.123B 0.00
electroCore, Inc. (ECOR) US $0.118B 0.00
Telomir Pharmaceuticals, Inc. (TELO) US $0.116B 0.00
Achieve Life Sciences, Inc. (ACHV) CA $0.109B 0.00
Journey Medical Corporation (DERM) US $0.108B 0.00
Corbus Pharmaceuticals Holdings, Inc. (CRBP) US $0.100B 0.00
Cardiol Therapeutics Inc. (CRDL) CA $0.099B 0.00
Galectin Therapeutics Inc. (GALT) US $0.094B 0.00
Arch Biopartners Inc. (ACHFF) CA $0.089B 0.00
Metagenomi, Inc. (MGX) US $0.088B 0.00
Avalo Therapeutics, Inc. (AVTX) US $0.088B 0.00
Regulus Therapeutics Inc. (RGLS) US $0.086B 0.00
Nutriband Inc. (NTRB) US $0.083B 0.00
Assertio Holdings, Inc. (ASRT) US $0.078B 20.32
Protara Therapeutics, Inc. (TARA) US $0.077B 0.00
ESSA Pharma Inc. (EPIX) CA $0.076B 0.00
Pyxis Oncology, Inc. (PYXS) US $0.076B 0.00
Karyopharm Therapeutics Inc. (KPTI) US $0.076B 0.00
Cumberland Pharmaceuticals Inc. (CPIX) US $0.075B 0.00
PMV Pharmaceuticals, Inc. (PMVP) US $0.073B 0.00
FibroGen, Inc (FGEN) US $0.071B 0.00
Mural Oncology PLC (MURA) IE $0.069B 0.00
Fractyl Health, Inc. (GUTS) US $0.068B 0.00
Vivani Medical, Inc. (VANI) US $0.068B 0.00
Unicycive Therapeutics, Inc. (UNCY) US $0.064B 0.00
Century Therapeutics, Inc. (IPSC) US $0.062B 0.00
AleAnna Inc. (ANNA) US $0.062B 0.00
Context Therapeutics Inc. (CNTX) US $0.061B 0.00
Gain Therapeutics, Inc. (GANX) US $0.060B 0.00
OptiNose, Inc. (OPTN) US $0.058B 0.00
Reviva Pharmaceuticals Holdings, Inc. (RVPH) US $0.053B 0.00
Dominari Holdings Inc. (DOMH) US $0.052B 0.00
Iterum Therapeutics PLC (ITRM) IE $0.052B 0.00
Rafael Holdings, Inc. (RFL) US $0.050B 0.00
AlloVir, Inc. (ALVR) US $0.049B 0.00
Prelude Therapeutics Incorporated (PRLD) US $0.048B 0.00
VYNE Therapeutics Inc. (VYNE) US $0.040B 0.00
NRx Pharmaceuticals, Inc. (NRXP) US $0.039B 0.00
CASI Pharmaceuticals Inc. (CASI) CN $0.038B 0.00
Tempest Therapeutics, Inc. (TPST) US $0.038B 0.00
Surrozen, Inc. (SRZN) US $0.036B 0.00
Verrica Pharmaceuticals Inc. (VRCA) US $0.034B 0.00
PolyPid Ltd. (PYPD) IL $0.030B 0.00
Incannex Healthcare Inc. (IXHL) AU $0.029B 0.00
Jupiter Neurosciences, Inc. (JUNS) US $0.028B 0.00
BioVie Inc. (BIVI) US $0.027B 0.00
Natural Alternatives International, Inc. (NAII) US $0.025B 0.00
DURECT Corporation (DRRX) US $0.025B 0.00
Scienture Holdings, Inc. (SCNX) US $0.024B 0.00
Enlivex Therapeutics Ltd. (ENLV) IL $0.021B 0.00
Mannatech, Incorporated (MTEX) US $0.021B 0.00
GlycoMimetics, Inc. (GLYC) US $0.019B 0.00
Carisma Therapeutics Inc. (CARM) US $0.019B 0.00
Vivos Therapeutics, Inc. (VVOS) US $0.018B 0.00
Lipocine Inc. (LPCN) US $0.018B 0.00
MEI Pharma, Inc. (MEIP) US $0.017B 0.00
Tonix Pharmaceuticals Holding Corp. (TNXP) US $0.017B 0.00
MARKER THERAPEUTICS, INC. (MRKR) US $0.017B 0.00
Traws Pharma, Inc. (TRAW) US $0.016B 0.00
Citius Pharmaceuticals, Inc. (CTXR) US $0.015B 0.00
Biomerica, Inc. (BMRA) US $0.015B 0.00
TherapeuticsMD, Inc. (TXMD) US $0.015B 0.00
Cosmos Health Inc. (COSM) US $0.014B 0.00
Lyra Therapeutics, Inc. (LYRA) US $0.013B 0.00
ProPhase Labs, Inc. (PRPH) US $0.013B 0.00
Minerva Neurosciences, Inc (NERV) US $0.013B 0.00
Nuvilex Inc. (PMCB) US $0.012B 0.00
BioLineRx Ltd. (BLRX) IL $0.012B 0.00
Phio Pharmaceuticals Corp. (PHIO) US $0.012B 0.00
Indaptus Therapeutics, Inc. (INDP) US $0.011B 0.00
Mangoceuticals, Inc. (MGRX) US $0.011B 0.00
Kiora Pharmaceuticals, Inc. (KPRX) US $0.010B 0.00
Klotho Neurosciences, Inc. (KLTO) US $0.010B 0.00
Talphera, Inc. (TLPH) US $0.010B 0.00
Jaguar Animal Health, Inc. (JAGX) US $0.010B 0.00
Relmada Therapeutics, Inc. (RLMD) US $0.009B 0.00
Ainos, Inc. (AIMD) US $0.009B 0.00
Addex Therapeutics Ltd. Sponsored ADR (ADXN) CH $0.008B 0.00
XTL Biopharmaceuticals Ltd. (XTLB) IL $0.008B 0.00
Plus Therapeutics, Inc. (PSTV) US $0.007B 0.00
NLS Pharmaceutics Ltd. (NLSP) CH $0.007B 0.00
Xenetic Biosciences, Inc. (XBIO) US $0.006B 0.00
Redhill Biopharma Ltd. (RDHL) IL $0.006B 0.00
Aptorum Group Limited (APM) GB $0.006B 0.00
TransCode Therapeutics Inc. (RNAZ) US $0.006B 0.00
Clearmind Medicine Inc. (CMND) CA $0.006B 0.00
CERo Therapeutics Holdings, Inc. (CERO) US $0.005B 0.00
SciSparc Ltd. (SPRC) IL $0.005B 0.00
Conduit Pharmaceuticals Inc. (CDT) US $0.004B 0.00
Sonoma Pharmaceuticals, Inc. (SNOA) US $0.004B 0.00
InMed Pharmaceuticals Inc. (INM) CA $0.004B 0.00
60 Degrees Pharmaceuticals Inc. (SXTP) US $0.003B 0.00
XORTX Therapeutics Inc. (XRTX) CA $0.003B 0.00
Avenue Therapeutics, Inc. (ATXI) US $0.003B 0.07
Alaunos Therapeutics, Inc. (TCRT) US $0.003B 0.00
Qualigen Therapeutics, Inc. (QLGN) US $0.003B 0.00
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) US $0.003B 0.00
SHINECO (SISI) CN $0.002B 0.00
Salarius Pharmaceuticals, Inc. (SLRX) US $0.002B 0.00
Galmed Pharmaceuticals Ltd. (GLMD) IL $0.002B 0.00
Heatwurx Inc. (PCSA) US $0.002B 0.00
Quoin Pharmaceuticals, Ltd. Sponsored ADR (QNRX) US $0.002B 0.00
Petros Pharmaceuticals, Inc. (PTPI) US $0.001B 0.00
China SXT Pharmaceuticals, Inc. (SXTC) CN $0.001B 0.00
TNF Pharmaceuticals, Inc. (TNFA) US $0.001B 0.00
Aditxt Inc. (ADTX) US $0.001B 0.00
PainReform Ltd. (PRFX) IL $0.000B 0.00
Universe Pharmaceuticals INC (UPC) CN $0.000B 0.00
4D pharma PLC Sponsored ADR (LBPS) GB $0.000B 0.00
Patheon N.V. (PTHN) NL $0.000B 0.00
RVL Pharmaceuticals PLC (RVLP) US $0.000B 0.00